본문 바로가기
KERD
논문KCI 등재

국내 노인 파킨슨병 환자에서의 잠재적으로 부적절한 약물사용 현황에 대한 연구

Assessment of Potentially Inappropriate Medication Use in Korean Elderly Patients with Parkinson’s Disease

0

조회

0

다운로드

3

인용

0

참고문헌

키워드

주제분류약학

초록

Objectives: The present study assessed the prevalence of the potentially inappropriate medication (PIM) use in Korean elderly patients with Parkinson’s disease. In addition, this study examined risk factors that affect PIM use. Method: A retrospective, observational study was conducted using Korean National Health Insurance claims database of 2009. PIM use in Parkinson’s disease patients aged 65 years or older was examined based on 2012 Beers Criteria. Multivariable logistic regression was conducted to identify risk factors for PIM use. Results: Among 5,277 elderly patients with Parkinson’s disease, 88.9% of patients used PIM(s) at least once. The average number of PIM items used per patient was 4.2. PIM use ratio, the proportion of total amount of PIMs to all medications per patient, was 12.6%. Frequently used PIM therapeutic classes were benzodiazepines (32.7%), firstgeneration antihistamines (19.2%), and prokinetics (17.5%). Individual PIMs most commonly used included chlorpheniramine (11.4%), levosulpiride (10.9%), diazepam (9.0%), and alprazolam (7.6%). Women (odds ratio [OR] 1.14, 95% confidence interval [CI] 1.11-1.16), medical aid (OR 1.18, 95% CI 1.15-1.21), and long-term facilities (OR 2.43, 95% CI 2.22-2.65) were shown to be risk factors associated with PIM use. Of particular, wide variation in PIM use was associated with the types of healthcare facility. Conclusion: The PIM prevalence was very high in elderly Parkinson’s disease patients. Nationally effective and systematic efforts to identify and prevent PIM use should be made to ensure patient safety and to improve quality of care in the elderly.

Abstract

Objectives: The present study assessed the prevalence of the potentially inappropriate medication (PIM) use in Korean elderly patients with Parkinson’s disease. In addition, this study examined risk factors that affect PIM use. Method: A retrospective, observational study was conducted using Korean National Health Insurance claims database of 2009. PIM use in Parkinson’s disease patients aged 65 years or older was examined based on 2012 Beers Criteria. Multivariable logistic regression was conducted to identify risk factors for PIM use. Results: Among 5,277 elderly patients with Parkinson’s disease, 88.9% of patients used PIM(s) at least once. The average number of PIM items used per patient was 4.2. PIM use ratio, the proportion of total amount of PIMs to all medications per patient, was 12.6%. Frequently used PIM therapeutic classes were benzodiazepines (32.7%), firstgeneration antihistamines (19.2%), and prokinetics (17.5%). Individual PIMs most commonly used included chlorpheniramine (11.4%), levosulpiride (10.9%), diazepam (9.0%), and alprazolam (7.6%). Women (odds ratio [OR] 1.14, 95% confidence interval [CI] 1.11-1.16), medical aid (OR 1.18, 95% CI 1.15-1.21), and long-term facilities (OR 2.43, 95% CI 2.22-2.65) were shown to be risk factors associated with PIM use. Of particular, wide variation in PIM use was associated with the types of healthcare facility. Conclusion: The PIM prevalence was very high in elderly Parkinson’s disease patients. Nationally effective and systematic efforts to identify and prevent PIM use should be made to ensure patient safety and to improve quality of care in the elderly.

참고문헌 (43)

  1. "Elderly statistics 2012" (2012)[URL]
  2. "2011 Korea Health Panel Survey"[URL]
  3. "Health Insurance Review & Assessment Service"[URL]
  4. Turnheim K, "When drug therapy gets old : pharmacokinetics and pharmacodynamics in the elderly", Exp Gerontol, 38(8), pp.843~853 (2003)
  5. McLean AJ., "Aging biology and geriatric clinical pharmacology", Pharmacol Rev, 56(2), pp.163~184 (2004)
  6. Gallagher P., "Inappropriate prescribing in the elderly", J Clin Pharm Ther, 32(2), pp.113~121 (2007)
  7. O’Mahony D., "Inappropriate prescribing in the older population : need for new criteria", Age Ageing, 37(2), pp.138~141 (2008)
  8. The American Geriatrics Society 2012 Beers Criteria Update Expert Panel, "American geriatrics society updated Beers criteria for potentially inappropriate medication use in older adults", J Am Geriatr Soc, 60(4), pp.616~631 (2012)
  9. Zhan C., "Potentially inappropriate medication use in the community-dwelling elderly : findings from the 1996medical expenditure panel survey", JAMA, 286(22), pp.2823~2829 (2001)
  10. McLeod PJ., "Defining inappropriate practices in prescribing for elderly people : a national consensus panel", CMAJ, 156(3), pp.385~391 (1997)
  11. Gallagher P., "STOPP (screening tool of older person’s prescriptions) and START (screening tool to alert doctors to right treatment). Consensus validation", Int J Clin Pharmacol Ther, 46(2), pp.72~83 (2008)
  12. Rognstad S., "The Norwegian general practice (NORGEP) criteria for assessing potentially inappropriate prescriptions to elderly patients. A modified delphi study", Scand J Prim Health Care, 27(3), pp.153~159 (2009)
  13. Winit-Watjana W., "Criteria for highrisk medication use in Thai older patients", Arch Gerontol Geriatr, 47(1), pp.35~51 (2008)
  14. Ministry of Food and Drug Safety., "Handbook of appropriate medication use for elderly" (2009)
  15. Chang CB., "Comparison of published explicit criteria for potentially inappropriate medications in older adults", Drugs Aging, 27(12), pp.947~957 (2010)
  16. Oh JM, "Drug use pattern and evaluation for appropriateness in geriatric patients", Ministry of Food and Drug Safety, ~ (2004)
  17. Kang IK., "Analysis of prescriptions for elderly at primary healthcare using national health insurance database", M.S., pp.2006
  18. Massano J., "Clinical approach to Parkinson’s disease: features, diagnosis, and principles of management", Cold Spring Harb Perspect Med, 2(6), pp.a008870~ (2012)
  19. Muzerengi S., "Non-motor symptoms:identification and management", Parkinsonism Relat Disord,, 13(Suppl 3), pp.S450~S456 (2007)
  20. De Lau LM., "Epidemiology of Parkinson’s disease", Lancet Neurol, 5(6), pp.525~535 (2006)
  21. "Nationwide survey on the prevalence of Parkinson’s disease in Korea"[URL]
  22. Williams-Gray CH., "The CamPaIGN study of Parkinson’s disease : 10-year outlook in an incident population-based cohort", J Neurol Neurosurg Psychiatry, 84(11), pp.1258~1264 (2013)
  23. Morgan JC., "Mortality in levodopatreated Parkinson’s disease", Parkinsons Dis, 2014, pp.426976~ (2014)
  24. Akazawa M., "Potentially inappropriate medication use in elderly Japanese patients", Am J Geriatr Pharmacother, 8(2), pp.146~160 (2010)
  25. Niwata S., "Prevalence of inappropriate medication using Beers criteria in Japanese long-term care facilities", BMC Geriatr, 6, pp.1~7 (2006)
  26. "The Korean standard classification of diseases and causes of death 2012"[URL]
  27. 배민경, "국내 노인 심부전 환자에서의 잠재적으로 부적절한 약물사용 현황에 대한 연구", 한국임상약학회지, 24(2), pp.115~125 (2014), 한국임상약학회
  28. 남진선, "한국의 외래노인환자에서 약물사용의 경향 및 explicit criteria에 의한 적절성평가", 한국임상약학회지, 15(2), pp.149~159 (2005), 한국임상약학회
  29. Fialová D., "Potentially inappropriate medication use among elderly home care patients in Europe", JAMA, 293(11), pp.1348~1358 (2005)
  30. Lai HY., "Prevalence of the prescribing of potentially inappropriate medications at ambulatory care visits by elderly patients covered by the Taiwanese national health insurance program", Clin Ther, 31(8), pp.1859~1870 (2009)
  31. Baldoni AO., "Factors associated with potentially inappropriate medications use by the elderly according to Beers criteria 2003 and 2012", Int J Clin Pharm, 36(2), pp.316~324 (2014)
  32. Chang CB., "Patient- and clinic visit-related factors associated with potentially inappropriate medication use among older home healthcare service recipients", PLoS One, 9(4), pp.e94350~ (2014)
  33. 전경숙, "의료이용의 남녀차이와 영향요인에 관한 연구", 한국보건간호학회지, 24(2), pp.182~196 (2010), 한국보건간호학회
  34. Kim YJ., "Benzodiazepine prescription patterns for the elderly patients at ambulatory care in Korea", JPERM, 1, pp.60~67 (2008)
  35. 전영선, "응급의료센터 내원 고령환자의 약물이상반응 현황 파악", 병원약사회지, 29(3), pp.271~280 (2012), 한국병원약사회
  36. Tune LE, "Anticholinergic effects of medication in elderly patients", J Clin Psychiatry, 62(Suppl 21), pp.11~14 (2001)
  37. Ancelin ML., "Non-degenerative mild cognitive impairment in elderly people and use of anticholinergic drugs : longitudinal cohort study", BMJ, 332(7539), pp.455~459 (2006)
  38. Grosset DG., "Diagnosis and pharmacological management of Parkinson’s disease: summary of SIGN guidelines", BMJ, 340, pp.b5614~ (2010)
  39. Grimes D., "Canadian guidelines on Parkinson’s disease", Can J Neurol Sci, 39(4 Suppl 4), pp.S1~S30 (2012)
  40. Ferreira JJ., "Summary of the recommendations of the EFNS", MDS-ES review on therapeutic management of Parkinson’s disease, 2013, pp.20(1), 5~15
  41. "Parkinson’s disease:Diagnosis and management in primary and secondary care"[URL]
  42. Schneider LS., "Risk of death with atypical antipsychotic drug treatment for dementia : meta-analysis of randomized placebo-controlled trials", JAMA, 294(15), pp.1934~1943 (2005)
  43. Wang PS., "Risk of death in elderly users of conventional vs. atypical antipsychotic medications", N Engl J Med, 353(22), pp.2335~2341 (2005)

관련 논문AI추천

이 간행물의 다른 논문 (10건)